Modified EXTREME regimen versus modified TPEx regimen as first-line treatment for recurrent or metastatic head and neck squamous cell carcinoma: a multicenter, open-label, randomized, exploratory study (TEMPER study)
Authors
Go Omura (ORCID: https://orcid.org/0000-0003-1042-3667)
Modified EXTREME regimen versus modified TPEx regimen as first-line treatment for recurrent or metastatic head and neck squamous cell carcinoma: a multicenter, open-label, randomized, exploratory study (TEMPER study)
Go Omura, Masafumi Kanno, Mioko Matsuo, 基之 鈴木 et al.
Journal
International Journal of Clinical Oncology
Topics
Head and Neck Cancer Studies
article
Modified EXTREME regimen versus modified TPEx regimen as first-line treatment for recurrent or metastatic head and neck squamous cell carcinoma: a multicenter, open-label, randomized, exploratory study (TEMPER study)
International Journal of Clinical OncologyVol. 31(4)
Institutions
Kanazawa University (JP), Kurume University (JP), University of Fukui (JP), Tokai University (JP), Kyushu University (JP), Yamaguchi University (JP), Wakayama Medical University (JP), Tohoku University (JP), Kagawa University (JP), Kyoto University (JP), Osaka Prefectural Medical Center (JP), University of the Ryukyus (JP), Kyoto Prefectural University of Medicine (JP), Osaka City General Hospital (JP), Osaka International Cancer Institute (JP), Osaka Rosai Hospital (JP), Keiyukai Sapporo Hospital (JP), Museum of Japanese Art Yamato Bunkakan (JP), Saitama International Medical Center (JP), Tokyo National Hospital (JP), Niigata University (JP), Hyogo University (JP), Saitama Medical University (JP), Tokushima University (JP), The University of Osaka (JP)